anagement of patients with aortic dissection includes medical and surgical treatments. Because of the high surgical morbidity and mortality rate, transluminal stent graft placement (TSGP) has emerged as a new treatment instead of open surgery for aortic dissection of a descending aortic intimal tear. 1 In our institute, we use TSGP to seal the entry site for both acute onset and chronic Standford B type aortic dissections. The implantation technique and outcome of this treatment are discussed. , 28 patients with type B aortic dissection, 23 men and 5 women, underwent TSGP. The table shows the baseline demographics and clinical characteristics of these patients. Patients were followed for 4 to 38 months, and the mean followup duration was (16.6 ± 9.7) months. Contrast enhanced spiral CT (n=9) or MRI (n=19) was taken to obtain the anatomical characteristics of the patients. The diameter of normal part of descending aorta was (30.2±7.3) mm with range from 26 to 34 mm; of proximal part of true lumen (26.1±8.2) mm with range from 21 to 35 mm and of distal part (15.3±9.4) mm with range from 8 to 26 mm. Distance from left subclavian artery to entry site was (26.6 ±9.2) mm with rangefrom 10 to 45 mm. The number of entry sites was 2.42±1.44 (range, 1 to 6).
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CLINICAL DATA Patients
Between March 2003 and March 2006, 28 patients with type B aortic dissection, 23 men and 5 women, underwent TSGP. The table shows the baseline demographics and clinical characteristics of these patients. Patients were followed for 4 to 38 months, and the mean followup duration was (16.6 ± 9.7) months. Contrast enhanced spiral CT (n=9) or MRI (n=19) was taken to obtain the anatomical characteristics of the patients. The diameter of normal part of descending aorta was (30.2±7.3) mm with range from 26 to 34 mm; of proximal part of true lumen (26.1±8.2) mm with range from 21 to 35 mm and of distal part (15.3±9.4) mm with range from 8 to 26 mm. Distance from left subclavian artery to entry site was (26.6 ±9.2) mm with rangefrom 10 to 45 mm. The number of entry sites was 2.42±1.44 (range, 1 to 6). 
Stent graft placement
The stent graft procedures have been described in detail in Dake's report. 2 Briefly, all implantations were performed under general anaesthesia with tracheal intubation. Aortography was done via a left subclavian artery with a 5-F pigtails catheter for precise guidance near the subclavian artery and for intraprocedural aortography. Aortography was performed before and after the stent graft deployment to confirm the location of the stent graft, the absence of perigraft leakage and the patency of adjacent branch vessels.
When the position of the wire in the true lumen of the aorta had been confirmed by fluoroscopy, the sheath with the stent and a deflated, large bore, latex balloon was introduced. The stent was expanded by inflation of balloon at 203-304 kPa. To ensure optimal positioning, care was taken to seal the entry with stent and to protect the left subclavian artery with the bare spring end of the stent.
Followup analysis
Followup CT performed within one week of the stent graft implantation determined the extent of thrombosis in the aortic false lumen, the size of the true and false lumens, the blood perfusion to the branch vessels and the position and shape of stent graft. Clinical information was compiled by two followup doctors by phone call and outpatient office interview.
Statistical analysis
Clinically important rates are reported with 95% confidence interval (95% CI), and continuous variables are expressed as means ± standard deviation (SD). SPSS 11.0 was used for statistical analysis.
RESULTS

Procedural success
TSGP was technically successful in 27 patients (96.4%) and no one died during the operation. One patient was given percutaneous surgery because the catheter cannot pass through the aortic true lumen. Sealing of the primary entry tear was monitored during the procedure by angiography and was successful in twenty-three patients immediately after the TSGP. Four patients had early type I endoleak through the proximal attachment site: two did not attend any followup; of them disappeared after replacement of stents. The other two attended first disappeared in the followup. The orifice of the left subclavian artery was occluded in two patients during the TSGP (Figs. 1, 2 ). There were two stent graft migrations and no stent graft torsion or folding in any patient. No patient required blood transfusion or inotropic support. Thirty eight stent grafts were used.
Early results of stent graft
One patient died of putrescence of mesenteric arterial embolism on the fifth day after operation with a mortality of 3.6% (95% CI 0 to 10.9%). Two patients experienced abdominal aortic dissection after TSGP (7.2%; 95% CI 0 to 17.4%) and one of them underwent TSGP again. There was not any renal insufficiency, heart failure, paraplegia or paralysis. Transient postimplantation syndrome with mild leukocytosis and moderately elevated body temperature occurred in 10 of the 28 patients. Thrombosis of aortic false lumen and enlargement of true lumen were revealed on CT in 27 patients. There was no migration and no stent graft torsion or folding during followup. The only minor complication was one superficial wound infection.
Later results of stent graft
During the followup of 4 to 38 months, 27 patients were well without having suffered aortic rupture, organ or limb ischaemia. At three months, there was clear evidence of expansion of the true lumen and shrinkage of the false lumen as a result of consolidation of thrombosis in all patients suggesting that the aortic tube had been remodelled with enlargement of the reconstructed true lumen. All the patients resumed an active life, all of them received on antihypertensive medication and none was readmitted to the hospital. Actuarial survival rate and cardiovascular event free rate were 96.4% (95% CI 89.1% to100%) and 100% overall after procedure at last followup.
DISCUSSION
Since Dake et al 2 reported the feasibility of endovascular stent grafting of descending thoracic aneurysms in 1994, some clinical experiences using TSGP for descending aortic disease have been reported. 3 The results showed that the effectiveness of the treatment was very encouraging, and there were only a few complications. However, the surgical mortality and morbidity rate are still around 20% to 60%. 4 Based on this experience, we ran a clinical trial of TSGP sealing the primary entry site in the descending thoracic aorta, not only in chronic aortic dissection, but also in three cases of acute onset. In our study, TSGP was successful in 27 patients There was no renal insufficiency, no heart failure, no paraplegia or paralysis. No one died in operation. Actuarial survival rate and cardiovascular event-free rate were 96.4% and 100% overall after procedure at last followup. Our data suggest that TSGP is an attractive treatment option for aortic dissection.
Type I endoleaks are the most frequent complication of stent graft treatment of aortic dissection, which could be a potential progression of the dissection during followup. 5, 6 In our series, 4 of 28 patients (14.3%) had early type I endoleak through the proximal attachment site. For type I endoleaks, we recommend regular followup imaging studies to see if there is any change in the dissected false lumen. Until an overt enlargement of the false lumen is detected, surgical management can be suggested.
Many different experiences showed that the incidence of spinal cord ischaemic complications was 7% to 35% of cases relative to intercostal artery sacrifice and aortic clamping during open repair. 7, 8 We have not experienced any cases of neurological complications in our patients.
The correct deployment far from vertebrae T 8 to L 2 can minimize the risk of paraplegia. Furthermore, the stent graft procedure took a short time without circulatory arrest and crossclamping of the aorta or associated ischaemia and reperfusion injury. It averted postoperative respiratory failure and prolonged hypotension and the associated risk of delayed paraplegia. Furthermore, in the case of aneurysms, many intercostals branches are already occluded and the spinal cord is perfused by collaterals. The sudden deployment of the stent graft, followed by the occlusion of the intercostal branches, does not produce Steal syndrome in the perfusion of the spinal cord.
With the use of TSGP in our study, the aorta was reconstructed with an excellent outcome and without the need for complex protective measures. Gentle manoeuvring of the guide wire and introducer could be the only way to lower the incidence of cerebral embolic complications. Correct location was based on the thoughtful analysis of the result of angiography and judgement of extent of true lumen. Aortic angiography by a 5-F pigtails catheter from abdominal aorta to aortic route and by another 5-F pigtails catheter via a left subclavian artery should combine together for precise guidance.
Nienaber 9 suggested that a primary entry tear located at least 10 mm distal to the orifice of the left subclavian artery to avoid the influence of blood supply of the left subcalvian artery. Among the patients with tears located at least 10 mm distal to the orifice, existence of entry tear located at small curvature of aortic arch shows high risk of endoleak. But many dissections have primary entry tears close to the orifices of the left subclavian arteries. We intentionally occluded orifice of left subclavian artery in two cases with the stent graft but they did not show ischaemia of their upper extremities or brain. It shows that the stent graft is a choice even for the patients with a primary entry tear located less than 10 mm distal to the orifice of the left subclavian artery.
In conclusion, TSGP is an efficient and safe modality for the treatment of type aortic dissection. However, various problems and complications could occur during the procedure and followup period. Thorough evaluation of preoperative imaging scans, meticulous procedure and close followup are mandatory to minimise such problems. Although initial results of TSGP of type B dissection are promising, the concept of nonsurgical management needs vindication by long term followup data.
